Deppe Michael J sold $3.1M of DGX
Deppe Michael J (SVP, Corp. Controller & CAO) sold 11,776 shares of QUEST DIAGNOSTICS INC (DGX) at $260.17 ($3.06M total) across 2 trades on 2026-11-13 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosure provides transparency on insider selling activity but does not include any new DGX business, financial, or regulatory developments.
Market read
Traders may monitor insider activity for sentiment, but the pre-arranged 10b5-1 nature reduces the likelihood of a material price reaction.
What to watch
10b5-1 plans are often set months in advance for diversification or tax planning, so the sale timing may not reflect current views on DGX.
Background
The article is an SEC Form 4 insider transaction disclosure for Quest Diagnostics (DGX).
Ticker impact
SEC Form 4 shows DGX SVP Michael J Deppe sold 11,776 shares for about $3.06M under a pre-arranged 10b5-1 plan.
Likely limited near-term impact as the sale is pre-arranged under 10b5-1, with any effect confined to marginal sentiment.
The filing specifies an S (open-market sale) and confirms a pre-arranged 10b5-1 plan; insider sales of this type are often routine and not indicative of new company fundamentals.
Market effects
Minimal, as this is a single-company insider transaction with no operational or guidance change.
None.
None.
Counterpoint
Some traders may read insider selling as a signal of reduced confidence, even if it is 10b5-1, and use it as a minor risk flag.
Key entities
- issuerQuest Diagnostics
DGX, the company whose insider transaction is disclosed.
- insiderMichael J. Deppe
SVP, Corporate Controller & CAO who sold shares under a 10b5-1 plan.


